NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cancer Research Horizons

Cancer Research Horizons

London, Englandcancerresearchuk.org

Overview

Cancer Research Horizons is the innovation arm of Cancer Research UK, the world's largest charitable funder of cancer research. It acts as a venture philanthropy fund focused on bridging the gap between academic research and commercialization by investing in early-stage oncology opportunities. It supports the creation of spin-out companies, provides seed funding, and facilitates partnerships to develop new cancer treatments, diagnostics, and medical devices. All financial returns are reinvested into the fund and into further cancer research.

Portfolio Companies

6

Investments

Cancer Research Horizons investments
CompanyDateStageLead
Infinitopes Precision ImmunomicsJan 2026SeedCo-investor
Laigo BioDec 2025SeedCo-investor
52NorthDec 2024SeedCo-investor
Myricx BioJul 2024Series ACo-investor
Mercy BioAnalyticsApr 2023Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.